These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22889197)

  • 1. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.
    Andrié RP; Becher UM; Frommold R; Tiyerili V; Schrickel JW; Nickenig G; Schwab JO
    Crit Care; 2012 Aug; 16(4):R152. PubMed ID: 22889197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
    Prondzinsky R; Lemm H; Swyter M; Wegener N; Unverzagt S; Carter JM; Russ M; Schlitt A; Buerke U; Christoph A; Schmidt H; Winkler M; Thiery J; Werdan K; Buerke M
    Crit Care Med; 2010 Jan; 38(1):152-60. PubMed ID: 19770739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of N-terminal pro-B-type natriuretic peptide in the prediction of outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock.
    Sharma YP; Kanabar K; Santosh K; Kasinadhuni G; Krishnappa D
    Indian Heart J; 2020; 72(4):302-305. PubMed ID: 32861389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
    Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
    Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Sanborn TA; Sleeper LA; Bates ER; Jacobs AK; Boland J; French JK; Dens J; Dzavik V; Palmeri ST; Webb JG; Goldberger M; Hochman JS
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1123-9. PubMed ID: 10985715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock.
    Prondzinsky R; Unverzagt S; Lemm H; Wegener NA; Schlitt A; Heinroth KM; Dietz S; Buerke U; Kellner P; Loppnow H; Fiedler MG; Thiery J; Werdan K; Buerke M
    Clin Res Cardiol; 2012 May; 101(5):375-84. PubMed ID: 22212516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data.
    Picariello C; Lazzeri C; Valente S; Chiostri M; Attanà P; Gensini GF
    Acute Card Care; 2010 Sep; 12(3):96-101. PubMed ID: 20698733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
    Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
    Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.
    Prondzinsky R; Unverzagt S; Lemm H; Wegener N; Heinroth K; Buerke U; Fiedler M; Thiery J; Haerting J; Werdan K; Buerke M
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):476-84. PubMed ID: 22810435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; Denks D; de Waha S; Pöss J; Heine GH; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2015 Jul; 191():159-66. PubMed ID: 25965624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
    Varpula M; Pulkki K; Karlsson S; Ruokonen E; Pettilä V;
    Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock.
    Phua J; Koay ES; Lee KH
    Shock; 2008 Mar; 29(3):328-33. PubMed ID: 18277855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected].
    Abdin A; Pöss J; Fuernau G; Ouarrak T; Desch S; Eitel I; de Waha S; Zeymer U; Böhm M; Thiele H
    Clin Res Cardiol; 2018 Jun; 107(6):517-523. PubMed ID: 29423774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin levels predict acute kidney injury and prognosis in acute pancreatitis: a prospective study.
    Huang HL; Nie X; Cai B; Tang JT; He Y; Miao Q; Song HL; Luo TX; Gao BX; Wang LL; Li GX
    PLoS One; 2013; 8(12):e82250. PubMed ID: 24349237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention.
    Picariello C; Lazzeri C; Chiostri M; Gensini G; Valente S
    Intern Emerg Med; 2009 Oct; 4(5):403-8. PubMed ID: 19585221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
    Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
    J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytic iron in acute myocardial infarction complicated by cardiogenic shock - A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Traeder F; Lele SS; Rajapurkar MM; Mukhopadhyay B; de Waha S; Desch S; Eitel I; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2017 Jan; 227():83-88. PubMed ID: 27865117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.